US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pyxis Oncology, Inc.

3.91

-0.4800-10.93%

Post-market: 3.88-0.0300-0.77%18:34 EST

Volume:1.74M

Turnover:6.88M

Market Cap:243.45M

PE:-2.48

High:4.39

Open:4.37

Low:3.67

Close:4.39

52wk High:5.55

52wk Low:0.8332

Shares:62.26M

Float Shares:41.16M

Volume Ratio:2.57

T/O Rate:4.23%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.5736

EPS(LYR):-1.3231

ROE:-87.28%

ROA:-34.33%

PB:3.54

PE(LYR):-2.96

Loading ...

Overview Company News Filings

Pyxis Oncology Q3 EPS USD -0.35

THOMSON REUTERS

Pyxis Oncology Inc - Expected Cash Runway Through Data Milestones and Into Second Half of 2026

THOMSON REUTERS

Press Release: Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results

Pyxis Oncology resumed with a Buy at Stifel

Pyxis Oncology’s PYX-201 Study: A Promising Step in Solid Tumor Treatment

Pyxis Oncology Announces New Clinical Data for MICVO ADC Targeting Solid Tumors to Be Presented at ESMO 2025 and AACR-NCI-EORTC

Pyxis Oncology appoints Alex Kane as Senior Vice President Investor Relations and Capital Markets

Kaltura Leads The Charge With Two Other Noteworthy Penny Stocks

Simply Wall St.

BRIEF-Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule

Pyxis Oncology Grants Stock Options to New Employees Under 2022 Inducement Plan in Accordance with Nasdaq Rules

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pyxis Oncology Initiated at Buy by Guggenheim

Guggenheim Initiates Pyxis Oncology at Buy With $5 Price Target

MT Newswires Live

Pyxis Oncology Inc. to Participate in Cantor Global Healthcare Conference and H.C. Wainwright Annual Global Investment Conference

Pyxis Oncology Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Pyxis Oncology Reports Q2 2025 Revenues of $2.8M, Net Loss Widens to $18.4M, EPS at ($0.30)

BRIEF-Pyxis Oncology Q2 Net Income USD -18.354 Million

Pyxis Oncology Q2 EPS USD -0.3

THOMSON REUTERS

Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update

Pyxis Oncology Inc expected to post a loss of 35 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PYXS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PYXS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PYXS\",,,,,undefined,":{"symbol":"PYXS","market":"US","secType":"STK","nameCN":"Pyxis Oncology, Inc.","latestPrice":3.91,"timestamp":1764709200000,"preClose":4.39,"halted":0,"volume":1741635,"hourTrading":{"tag":"盘后","latestPrice":3.88,"preClose":3.91,"latestTime":"18:34 EST","volume":5378,"amount":20703.987768000003,"timestamp":1764718453617},"delay":0,"floatShares":41156263,"shares":62264215,"eps":-1.573588,"marketStatus":"Post-Mkt","change":-0.48,"latestTime":"12-02 19:02:40 EST","open":4.37,"high":4.39,"low":3.67,"amount":6881643.305271,"amplitude":0.164009,"askPrice":3.93,"askSize":249,"bidPrice":3.78,"bidSize":5,"shortable":0,"etf":0,"ttmEps":-1.573588,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1764723600000},"marketStatusCode":4,"adr":0,"listingDate":1633665600000,"exchange":"NASDAQ","adjPreClose":4.39,"preHourTrading":{"tag":"盘前","latestPrice":4.4581,"preClose":4.39,"latestTime":"09:16 EST","volume":10620,"amount":45931.578588,"timestamp":1764685013328},"postHourTrading":{"tag":"盘后","latestPrice":3.88,"preClose":3.91,"latestTime":"18:34 EST","volume":5378,"amount":20703.987768000003,"timestamp":1764718453617},"volumeRatio":2.569468,"impliedVol":3.8175,"impliedVolPercentile":0.968},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PYXS\",,,,,undefined,":{"symbol":"PYXS","floatShares":41156263,"roa":"-34.33%","roe":"-87.28%","lyrEps":-1.323124,"volumeRatio":2.569468,"shares":62264215,"dividePrice":0,"high":4.39,"amplitude":0.164009,"preClose":4.39,"low":3.67,"week52Low":0.8332,"pbRate":"3.54","psRate":"86.33","week52High":5.55,"institutionHeld":0,"latestPrice":3.91,"committee":-0.96063,"eps":-1.573588,"divideRate":0,"volume":1741635,"delay":0,"ttmEps":-1.573588,"open":4.37,"prevYearClose":1.56,"prevWeekClose":5.19,"prevMonthClose":5.19,"prevQuarterClose":2.22,"fiveDayClose":5.15,"twentyDayClose":3.81,"sixtyDayClose":1.96},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PYXS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-03","symbol":"PYXS","fiscalQuarterEnding":"2025/09","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762146000000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-08-14","symbol":"PYXS","fiscalQuarterEnding":"2025/06","expectedEps":-0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.3},{"market":"US","date":"2025-05-15","symbol":"PYXS","fiscalQuarterEnding":"2025/03","expectedEps":-0.29,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-03-18","symbol":"PYXS","fiscalQuarterEnding":"2024/12","expectedEps":-0.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2024-11-12","symbol":"PYXS","fiscalQuarterEnding":"2024/09","expectedEps":-0.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.35}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PYXS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PYXS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5556,"buy":0.3333,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":9,"updateTime":1762405200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PYXS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PYXS","date":"2025-12-01","current":-2.484767,"percent":0.217306,"low":-8.295353,"twenty":-3.449057,"median":-1.109339,"eighty":-0.767362,"high":-0.361135,"avg":-1.944366,"sd":1.65416,"marketCap":323151275},"quantilePoints":[{"date":"2021-10-08","current":-8.027761,"twenty":-7.000853,"median":-5.460491,"eighty":-3.942431,"marketCap":423392125},{"date":"2021-10-15","current":-7.158087,"twenty":-7.278503,"median":-7.179372,"eighty":-6.139529,"marketCap":377524644},{"date":"2021-10-22","current":-7.924373,"twenty":-7.797875,"median":-7.194576,"eighty":-7.01456,"marketCap":417939347},{"date":"2021-10-29","current":-8.112904,"twenty":-7.957214,"median":-7.453046,"eighty":-7.096054,"marketCap":427882647},{"date":"2021-11-05","current":-7.346617,"twenty":-8.064251,"median":-7.83923,"eighty":-7.160519,"marketCap":387467944},{"date":"2021-11-12","current":-7.188495,"twenty":-8.027761,"median":-7.453046,"eighty":-7.150789,"marketCap":379128403},{"date":"2021-11-19","current":-6.530285,"twenty":-8.0083,"median":-7.297964,"eighty":-6.572742,"marketCap":416142385},{"date":"2021-11-26","current":-6.489849,"twenty":-7.968161,"median":-7.194576,"eighty":-6.360457,"marketCap":413565652},{"date":"2021-12-03","current":-6.161313,"twenty":-7.92194,"median":-7.161128,"eighty":-6.269642,"marketCap":392629696},{"date":"2021-12-10","current":-4.599504,"twenty":-7.909777,"median":-7.054699,"eighty":-6.108748,"marketCap":293103383},{"date":"2021-12-17","current":-4.29624,"twenty":-7.887883,"median":-6.583356,"eighty":-5.099226,"marketCap":273777885},{"date":"2021-12-23","current":-4.958366,"twenty":-7.83923,"median":-6.472159,"eighty":-4.735973,"marketCap":315971889},{"date":"2021-12-31","current":-5.544677,"twenty":-7.608128,"median":-6.388761,"eighty":-4.857278,"marketCap":353334518},{"date":"2022-01-07","current":-5.104944,"twenty":-7.510822,"median":-6.288084,"eighty":-4.857278,"marketCap":325312546},{"date":"2022-01-14","current":-5.206032,"twenty":-7.39527,"median":-6.161313,"eighty":-4.872441,"marketCap":331754378},{"date":"2022-01-21","current":-4.811789,"twenty":-7.356348,"median":-6.100661,"eighty":-4.857278,"marketCap":306631231},{"date":"2022-01-28","current":-4.25075,"twenty":-7.307695,"median":-5.81256,"eighty":-4.84818,"marketCap":270879060},{"date":"2022-02-04","current":-4.321512,"twenty":-7.259042,"median":-5.504241,"eighty":-4.792582,"marketCap":275388343},{"date":"2022-02-11","current":-3.811017,"twenty":-7.205523,"median":-5.368642,"eighty":-4.623765,"marketCap":242857089},{"date":"2022-02-18","current":-3.654331,"twenty":-7.189711,"median":-5.206032,"eighty":-4.399349,"marketCap":232872248},{"date":"2022-02-25","current":-3.159,"twenty":-7.173899,"median":-5.104944,"eighty":-4.333642,"marketCap":201307268},{"date":"2022-03-04","current":-2.22899,"twenty":-7.160519,"median":-5.074618,"eighty":-4.262881,"marketCap":142042408},{"date":"2022-03-11","current":-2.330078,"twenty":-7.150789,"median":-5.00891,"eighty":-4.128434,"marketCap":148484241},{"date":"2022-03-18","current":-2.754648,"twenty":-7.091189,"median":-4.948257,"eighty":-3.780691,"marketCap":175539938},{"date":"2022-03-25","current":-2.375568,"twenty":-7.01456,"median":-4.892659,"eighty":-3.269185,"marketCap":151383066},{"date":"2022-04-01","current":-1.514143,"twenty":-6.776977,"median":-4.864859,"eighty":-2.912659,"marketCap":115037013},{"date":"2022-04-08","current":-1.594728,"twenty":-6.572742,"median":-4.821897,"eighty":-2.615147,"marketCap":121159431},{"date":"2022-04-14","current":-1.548073,"twenty":-6.514111,"median":-4.811789,"eighty":-2.474634,"marketCap":117614873},{"date":"2022-04-22","current":-1.246941,"twenty":-6.475697,"median":-4.756191,"eighty":-2.394775,"marketCap":94736363},{"date":"2022-04-29","current":-1.038157,"twenty":-6.428186,"median":-4.62983,"eighty":-2.330078,"marketCap":78873989},{"date":"2022-05-06","current":-0.961884,"twenty":-6.388761,"median":-4.480726,"eighty":-2.254263,"marketCap":73079165},{"date":"2022-05-13","current":-0.86541,"twenty":-6.374609,"median":-4.387219,"eighty":-1.911128,"marketCap":61037378},{"date":"2022-05-20","current":-0.951094,"twenty":-6.339557,"median":-4.33162,"eighty":-1.594728,"marketCap":67080683},{"date":"2022-05-27","current":-1.066768,"twenty":-6.294231,"median":-4.29624,"eighty":-1.532805,"marketCap":75239144},{"date":"2022-06-03","current":-1.0582,"twenty":-6.247238,"median":-4.25075,"eighty":-1.347884,"marketCap":74634814},{"date":"2022-06-10","current":-1.02821,"twenty":-6.197705,"median":-4.190098,"eighty":-1.189259,"marketCap":72519657},{"date":"2022-06-17","current":-1.015357,"twenty":-6.15727,"median":-4.04352,"eighty":-1.12564,"marketCap":71613161},{"date":"2022-06-24","current":-1.002505,"twenty":-6.141096,"median":-3.811017,"eighty":-1.072056,"marketCap":70706666},{"date":"2022-07-01","current":-1.045347,"twenty":-6.100661,"median":-3.677076,"eighty":-1.066768,"marketCap":73728318},{"date":"2022-07-08","current":-1.182442,"twenty":-6.096617,"median":-3.260088,"eighty":-1.066768,"marketCap":83397606},{"date":"2022-07-15","current":-1.27241,"twenty":-5.897474,"median":-3.073075,"eighty":-1.066768,"marketCap":89743076},{"date":"2022-07-22","current":-1.203863,"twenty":-5.791331,"median":-2.820355,"eighty":-1.066768,"marketCap":84908432},{"date":"2022-07-29","current":-1.135315,"twenty":-5.591177,"median":-2.643451,"eighty":-1.070195,"marketCap":80073788},{"date":"2022-08-05","current":-1.195294,"twenty":-5.512328,"median":-2.506983,"eighty":-1.071052,"marketCap":84304101},{"date":"2022-08-12","current":-1.250989,"twenty":-5.504241,"median":-2.451384,"eighty":-1.071855,"marketCap":88232250},{"date":"2022-08-19","current":-1.008852,"twenty":-5.469241,"median":-2.395786,"eighty":-1.066768,"marketCap":88724535},{"date":"2022-08-26","current":-0.940916,"twenty":-5.313533,"median":-2.360405,"eighty":-1.061627,"marketCap":82749819},{"date":"2022-09-02","current":-0.930726,"twenty":-5.276793,"median":-2.314915,"eighty":-1.048774,"marketCap":81853611},{"date":"2022-09-09","current":-0.913742,"twenty":-5.234336,"median":-2.292171,"eighty":-1.039901,"marketCap":80359932},{"date":"2022-09-16","current":-0.750695,"twenty":-5.145379,"median":-2.22899,"eighty":-1.023926,"marketCap":66020614},{"date":"2022-09-23","current":-0.655584,"twenty":-5.104944,"median":-1.912825,"eighty":-1.019402,"marketCap":57656011},{"date":"2022-09-30","current":-0.669171,"twenty":-5.092813,"median":-1.713484,"eighty":-1.014114,"marketCap":58850954},{"date":"2022-10-07","current":-0.65041,"twenty":-5.081694,"median":-1.594728,"eighty":-1.005075,"marketCap":57200979},{"date":"2022-10-14","current":-0.617524,"twenty":-5.073607,"median":-1.548073,"eighty":-0.983479,"marketCap":54308795},{"date":"2022-10-21","current":-0.61387,"twenty":-5.069563,"median":-1.480212,"eighty":-0.968263,"marketCap":53987441},{"date":"2022-10-28","current":-0.68695,"twenty":-5.033171,"median":-1.314802,"eighty":-0.940828,"marketCap":60414518},{"date":"2022-11-04","current":-0.484681,"twenty":-4.978584,"median":-1.27452,"eighty":-0.92665,"marketCap":49168502},{"date":"2022-11-11","current":-0.47201,"twenty":-4.952301,"median":-1.27241,"eighty":-0.914661,"marketCap":47883051},{"date":"2022-11-18","current":-0.443499,"twenty":-4.948257,"median":-1.248965,"eighty":-0.896339,"marketCap":44990786},{"date":"2022-11-25","current":-0.481514,"twenty":-4.926018,"median":-1.240279,"eighty":-0.882491,"marketCap":48847139},{"date":"2022-12-02","current":-0.438748,"twenty":-4.892659,"median":-1.220999,"eighty":-0.86541,"marketCap":44508742},{"date":"2022-12-09","current":-0.392814,"twenty":-4.884572,"median":-1.212431,"eighty":-0.769717,"marketCap":39848982},{"date":"2022-12-16","current":-0.367471,"twenty":-4.872441,"median":-1.195294,"eighty":-0.689873,"marketCap":37278080},{"date":"2022-12-23","current":-0.405485,"twenty":-4.866376,"median":-1.17864,"eighty":-0.672428,"marketCap":41134433},{"date":"2022-12-30","current":-0.424492,"twenty":-4.857278,"median":-1.172214,"eighty":-0.663737,"marketCap":43062609},{"date":"2023-01-06","current":-0.459339,"twenty":-4.857278,"median":-1.165305,"eighty":-0.655584,"marketCap":46597600},{"date":"2023-01-13","current":-0.484681,"twenty":-4.821897,"median":-1.161021,"eighty":-0.65041,"marketCap":49168502},{"date":"2023-01-20","current":-0.503688,"twenty":-4.817854,"median":-1.148168,"eighty":-0.637308,"marketCap":51096678},{"date":"2023-01-27","current":-0.503688,"twenty":-4.8128,"median":-1.133871,"eighty":-0.620447,"marketCap":51096678},{"date":"2023-02-03","current":-0.510024,"twenty":-4.807745,"median":-1.10961,"eighty":-0.601446,"marketCap":51739404},{"date":"2023-02-10","current":-0.478346,"twenty":-4.782473,"median":-1.075336,"eighty":-0.518894,"marketCap":48525776},{"date":"2023-02-17","current":-0.535367,"twenty":-4.74406,"median":-1.071052,"eighty":-0.515093,"marketCap":54310306},{"date":"2023-02-24","current":-0.715935,"twenty":-4.699581,"median":-1.066768,"eighty":-0.51636,"marketCap":72627983},{"date":"2023-03-03","current":-0.719102,"twenty":-4.648026,"median":-1.066768,"eighty":-0.518261,"marketCap":72949346},{"date":"2023-03-10","current":-0.56071,"twenty":-4.611634,"median":-1.062484,"eighty":-0.521429,"marketCap":56881208},{"date":"2023-03-17","current":-0.874327,"twenty":-4.569178,"median":-1.053916,"eighty":-0.530299,"marketCap":88696121},{"date":"2023-03-24","current":-0.621811,"twenty":-4.467079,"median":-1.045347,"eighty":-0.535367,"marketCap":75063167},{"date":"2023-03-31","current":-1.128264,"twenty":-4.406426,"median":-1.049631,"eighty":-0.539965,"marketCap":136200588},{"date":"2023-04-06","current":-1.0326,"twenty":-4.396317,"median":-1.049631,"eighty":-0.550102,"marketCap":124652408},{"date":"2023-04-14","current":-0.996023,"twenty":-4.375089,"median":-1.049631,"eighty":-0.561512,"marketCap":120236928},{"date":"2023-04-21","current":-0.93131,"twenty":-4.350827,"median":-1.045347,"eighty":-0.564447,"marketCap":112424924},{"date":"2023-04-28","current":-0.796256,"twenty":-4.333642,"median":-1.038157,"eighty":-0.578468,"marketCap":96121612},{"date":"2023-05-05","current":-0.83137,"twenty":-4.313425,"median":-1.028722,"eighty":-0.598523,"marketCap":100360456},{"date":"2023-05-12","current":-0.880615,"twenty":-4.299272,"median":-1.023926,"eighty":-0.605036,"marketCap":106305152},{"date":"2023-05-19","current":-1.116393,"twenty":-4.286131,"median":-1.028722,"eighty":-0.610485,"marketCap":121217968},{"date":"2023-05-26","current":-0.929527,"twenty":-4.262881,"median":-1.029233,"eighty":-0.615332,"marketCap":100927993},{"date":"2023-06-02","current":-0.990896,"twenty":-4.248728,"median":-1.023926,"eighty":-0.617524,"marketCap":107591516},{"date":"2023-06-09","current":-0.889112,"twenty":-4.231543,"median":-1.019642,"eighty":-0.617565,"marketCap":96539820},{"date":"2023-06-16","current":-0.904081,"twenty":-4.19313,"median":-1.019043,"eighty":-0.617984,"marketCap":98165069},{"date":"2023-06-23","current":-0.814271,"twenty":-4.185043,"median":-1.018532,"eighty":-0.618997,"marketCap":88413572},{"date":"2023-06-30","current":-0.773857,"twenty":-4.071825,"median":-1.015357,"eighty":-0.620742,"marketCap":84025399},{"date":"2023-07-07","current":-0.724462,"twenty":-4.04352,"median":-1.008852,"eighty":-0.621558,"marketCap":78662075},{"date":"2023-07-14","current":-0.832233,"twenty":-4.001063,"median":-1.004647,"eighty":-0.623624,"marketCap":90363872},{"date":"2023-07-21","current":-0.769367,"twenty":-3.875713,"median":-0.998221,"eighty":-0.627024,"marketCap":83537824},{"date":"2023-07-28","current":-0.82668,"twenty":-3.765527,"median":-0.993459,"eighty":-0.629636,"marketCap":89760926},{"date":"2023-08-04","current":-0.868894,"twenty":-3.713973,"median":-0.985075,"eighty":-0.631445,"marketCap":94344463},{"date":"2023-08-11","current":-0.851305,"twenty":-3.672527,"median":-0.976564,"eighty":-0.632998,"marketCap":92434656},{"date":"2023-08-18","current":-0.898223,"twenty":-3.445079,"median":-0.976328,"eighty":-0.635471,"marketCap":88851359},{"date":"2023-08-25","current":-0.935024,"twenty":-3.25099,"median":-0.975262,"eighty":-0.637855,"marketCap":92491636},{"date":"2023-08-31","current":-0.935024,"twenty":-3.192359,"median":-0.973294,"eighty":-0.638939,"marketCap":92491636},{"date":"2023-09-08","current":-0.943887,"twenty":-3.141815,"median":-0.974334,"eighty":-0.640637,"marketCap":93368334},{"date":"2023-09-15","current":-0.966044,"twenty":-3.044538,"median":-0.974596,"eighty":-0.646397,"marketCap":95560079},{"date":"2023-09-22","current":-0.771062,"twenty":-2.921525,"median":-0.969731,"eighty":-0.650765,"marketCap":76272724},{"date":"2023-09-29","current":-0.904004,"twenty":-2.859779,"median":-0.965073,"eighty":-0.652187,"marketCap":89423193},{"date":"2023-10-06","current":-0.89071,"twenty":-2.744539,"median":-0.959532,"eighty":-0.652265,"marketCap":88108146},{"date":"2023-10-13","current":-0.864122,"twenty":-2.691973,"median":-0.95275,"eighty":-0.652875,"marketCap":85478053},{"date":"2023-10-20","current":-0.771062,"twenty":-2.629299,"median":-0.948916,"eighty":-0.654368,"marketCap":76272724},{"date":"2023-10-27","current":-0.691297,"twenty":-2.600994,"median":-0.945798,"eighty":-0.654976,"marketCap":68382442},{"date":"2023-11-03","current":-0.771062,"twenty":-2.545396,"median":-0.940916,"eighty":-0.655584,"marketCap":76272724},{"date":"2023-11-10","current":-0.697312,"twenty":-2.502939,"median":-0.938487,"eighty":-0.655584,"marketCap":65752348},{"date":"2023-11-17","current":-0.690685,"twenty":-2.474634,"median":-0.935024,"eighty":-0.65966,"marketCap":65127425},{"date":"2023-11-24","current":-0.728273,"twenty":-2.460482,"median":-0.935024,"eighty":-0.665095,"marketCap":68671775},{"date":"2023-12-01","current":-0.747067,"twenty":-2.441275,"median":-0.93131,"eighty":-0.669171,"marketCap":70443949},{"date":"2023-12-08","current":-0.977295,"twenty":-2.416003,"median":-0.930726,"eighty":-0.670259,"marketCap":92153091},{"date":"2023-12-15","current":-0.831641,"twenty":-2.396796,"median":-0.924102,"eighty":-0.671891,"marketCap":78418736},{"date":"2023-12-22","current":-0.784655,"twenty":-2.384666,"median":-0.920535,"eighty":-0.672068,"marketCap":73988299},{"date":"2023-12-29","current":-0.841038,"twenty":-2.375568,"median":-0.91698,"eighty":-0.672334,"marketCap":79304824},{"date":"2024-01-05","current":-0.9632,"twenty":-2.36647,"median":-0.920535,"eighty":-0.672474,"marketCap":90823960},{"date":"2024-01-12","current":-1.137046,"twenty":-2.342209,"median":-0.924102,"eighty":-0.674981,"marketCap":107216577},{"date":"2024-01-19","current":-1.021931,"twenty":-2.330078,"median":-0.930127,"eighty":-0.677698,"marketCap":96362006},{"date":"2024-01-26","current":-1.484737,"twenty":-2.317948,"median":-0.93131,"eighty":-0.680936,"marketCap":140001812},{"date":"2024-02-02","current":-1.743157,"twenty":-2.299752,"median":-0.935024,"eighty":-0.68368,"marketCap":164369216},{"date":"2024-02-09","current":-1.743157,"twenty":-2.293687,"median":-0.937011,"eighty":-0.685334,"marketCap":164369216},{"date":"2024-02-16","current":-2.626481,"twenty":-2.299752,"median":-0.940076,"eighty":-0.68714,"marketCap":247661433},{"date":"2024-02-23","current":-2.227106,"twenty":-2.305535,"median":-0.942402,"eighty":-0.688076,"marketCap":210002718},{"date":"2024-03-01","current":-2.988269,"twenty":-2.330078,"median":-0.94771,"eighty":-0.690807,"marketCap":281775799},{"date":"2024-03-08","current":-2.927188,"twenty":-2.389016,"median":-0.951922,"eighty":-0.691889,"marketCap":276016231},{"date":"2024-03-15","current":-2.227106,"twenty":-2.44633,"median":-0.953803,"eighty":-0.694552,"marketCap":210002718},{"date":"2024-03-22","current":-2.978041,"twenty":-2.463514,"median":-0.959532,"eighty":-0.695729,"marketCap":219749680},{"date":"2024-03-28","current":-3.308852,"twenty":-2.5272,"median":-0.963576,"eighty":-0.695729,"marketCap":244160175},{"date":"2024-04-05","current":-4.049404,"twenty":-2.643451,"median":-0.966044,"eighty":-0.696346,"marketCap":298805547},{"date":"2024-04-12","current":-4.151821,"twenty":-2.729849,"median":-0.970206,"eighty":-0.696927,"marketCap":306362886},{"date":"2024-04-19","current":-3.568833,"twenty":-2.927188,"median":-0.974596,"eighty":-0.696927,"marketCap":263344188},{"date":"2024-04-26","current":-3.387634,"twenty":-2.988269,"median":-0.976564,"eighty":-0.697312,"marketCap":249973512},{"date":"2024-05-03","current":-3.5187,"twenty":-3.030555,"median":-0.978065,"eighty":-0.699743,"marketCap":259644879},{"date":"2024-05-10","current":-3.598489,"twenty":-3.143409,"median":-0.983769,"eighty":-0.709023,"marketCap":265532518},{"date":"2024-05-17","current":-4.247436,"twenty":-3.277339,"median":-0.985368,"eighty":-0.709479,"marketCap":245514546},{"date":"2024-05-24","current":-3.890937,"twenty":-3.387634,"median":-0.992012,"eighty":-0.709599,"marketCap":224907809},{"date":"2024-05-31","current":-3.789857,"twenty":-3.432528,"median":-0.994328,"eighty":-0.710926,"marketCap":219065119},{"date":"2024-06-07","current":-3.606477,"twenty":-3.496972,"median":-0.998221,"eighty":-0.713593,"marketCap":208465194},{"date":"2024-06-14","current":-4.024176,"twenty":-3.528275,"median":-1.002505,"eighty":-0.715232,"marketCap":232609468},{"date":"2024-06-21","current":-3.443472,"twenty":-3.544174,"median":-1.006789,"eighty":-0.717202,"marketCap":199043038},{"date":"2024-06-28","current":-3.27028,"twenty":-3.546282,"median":-1.006789,"eighty":-0.718469,"marketCap":189031998},{"date":"2024-07-05","current":-2.934083,"twenty":-3.543661,"median":-1.012249,"eighty":-0.719102,"marketCap":169598802},{"date":"2024-07-12","current":-3.025773,"twenty":-3.528275,"median":-1.017751,"eighty":-0.722318,"marketCap":174898764},{"date":"2024-07-15","current":-3.209153,"twenty":-3.523487,"median":-1.018532,"eighty":-0.72339,"marketCap":185498689},{"date":"2024-08-02","current":-3.759294,"twenty":-3.542637,"median":-1.018787,"eighty":-0.724462,"marketCap":217298465},{"date":"2024-08-09","current":-3.54535,"twenty":-3.542637,"median":-1.01922,"eighty":-0.726748,"marketCap":204931886},{"date":"2024-08-16","current":-3.414893,"twenty":-3.535163,"median":-1.019642,"eighty":-0.728273,"marketCap":202171893},{"date":"2024-08-23","current":-3.633924,"twenty":-3.545198,"median":-1.023926,"eighty":-0.728273,"marketCap":215139186},{"date":"2024-08-30","current":-3.64388,"twenty":-3.568833,"median":-1.028147,"eighty":-0.728273,"marketCap":215728609},{"date":"2024-09-06","current":-3.484584,"twenty":-3.574764,"median":-1.029598,"eighty":-0.728273,"marketCap":206297850},{"date":"2024-09-13","current":-3.623968,"twenty":-3.60454,"median":-1.038157,"eighty":-0.730014,"marketCap":214549764},{"date":"2024-09-20","current":-3.663792,"twenty":-3.616003,"median":-1.045347,"eighty":-0.730587,"marketCap":216907454},{"date":"2024-09-27","current":-3.73382,"twenty":-3.623968,"median":-1.049631,"eighty":-0.732502,"marketCap":221053355},{"date":"2024-10-04","current":-3.52304,"twenty":-3.625864,"median":-1.057271,"eighty":-0.738629,"marketCap":208574536},{"date":"2024-10-11","current":-3.166721,"twenty":-3.623968,"median":-1.062484,"eighty":-0.745662,"marketCap":187479391},{"date":"2024-10-18","current":-3.242,"twenty":-3.616003,"median":-1.065075,"eighty":-0.747504,"marketCap":191936112},{"date":"2024-10-25","current":-3.763932,"twenty":-3.625864,"median":-1.066768,"eighty":-0.747613,"marketCap":222836043},{"date":"2024-10-31","current":-3.784006,"twenty":-3.637906,"median":-1.066768,"eighty":-0.748092,"marketCap":224024502},{"date":"2024-11-08","current":-3.954637,"twenty":-3.663792,"median":-1.071052,"eighty":-0.748411,"marketCap":234126403},{"date":"2024-11-15","current":-4.437354,"twenty":-3.685372,"median":-1.075336,"eighty":-0.749781,"marketCap":254513320},{"date":"2024-11-22","current":-2.177206,"twenty":-3.694157,"median":-1.080597,"eighty":-0.752917,"marketCap":124878030},{"date":"2024-11-29","current":-2.083898,"twenty":-3.693667,"median":-1.083246,"eighty":-0.755737,"marketCap":119526115},{"date":"2024-12-06","current":-1.7625,"twenty":-3.691387,"median":-1.086059,"eighty":-0.758203,"marketCap":101091739},{"date":"2024-12-13","current":-1.575883,"twenty":-3.686241,"median":-1.106883,"eighty":-0.759205,"marketCap":90387908},{"date":"2024-12-20","current":-1.596618,"twenty":-3.67968,"median":-1.116393,"eighty":-0.76056,"marketCap":91577222},{"date":"2024-12-27","current":-1.679559,"twenty":-3.673718,"median":-1.116393,"eighty":-0.762678,"marketCap":96334480},{"date":"2025-01-03","current":-1.752133,"twenty":-3.673597,"median":-1.123944,"eighty":-0.765861,"marketCap":100497082},{"date":"2025-01-10","current":-1.669192,"twenty":-3.665753,"median":-1.128264,"eighty":-0.766468,"marketCap":95739823},{"date":"2025-01-17","current":-1.524045,"twenty":-3.663792,"median":-1.133871,"eighty":-0.766629,"marketCap":87414621},{"date":"2025-01-24","current":-1.700295,"twenty":-3.658115,"median":-1.136181,"eighty":-0.768273,"marketCap":97523795},{"date":"2025-01-31","current":-1.679559,"twenty":-3.64806,"median":-1.148168,"eighty":-0.769367,"marketCap":96334480},{"date":"2025-02-07","current":-1.524045,"twenty":-3.64388,"median":-1.161021,"eighty":-0.770083,"marketCap":87414621},{"date":"2025-02-14","current":-1.347794,"twenty":-3.637906,"median":-1.165305,"eighty":-0.77056,"marketCap":77305447},{"date":"2025-02-21","current":-1.41,"twenty":-3.633924,"median":-1.174839,"eighty":-0.770761,"marketCap":80873391},{"date":"2025-02-28","current":-1.171544,"twenty":-3.633734,"median":-1.174839,"eighty":-0.771062,"marketCap":67196273},{"date":"2025-03-07","current":-1.223383,"twenty":-3.629657,"median":-1.181912,"eighty":-0.771062,"marketCap":70169560},{"date":"2025-03-14","current":-1.109339,"twenty":-3.623968,"median":-1.174839,"eighty":-0.771062,"marketCap":63628330},{"date":"2025-03-21","current":-0.892026,"twenty":-3.623745,"median":-1.171544,"eighty":-0.771314,"marketCap":68981264},{"date":"2025-03-28","current":-0.868132,"twenty":-3.619651,"median":-1.167447,"eighty":-0.772558,"marketCap":67133552},{"date":"2025-04-04","current":-0.745081,"twenty":-3.613757,"median":-1.161021,"eighty":-0.771314,"marketCap":57617833},{"date":"2025-04-11","current":-0.722621,"twenty":-3.613374,"median":-1.150809,"eighty":-0.771062,"marketCap":55880983},{"date":"2025-04-17","current":-0.743806,"twenty":-3.611995,"median":-1.149569,"eighty":-0.769606,"marketCap":57519288},{"date":"2025-04-25","current":-0.868132,"twenty":-3.605993,"median":-1.145145,"eighty":-0.769606,"marketCap":67133552},{"date":"2025-05-02","current":-0.876097,"twenty":-3.602943,"median":-1.135315,"eighty":-0.77056,"marketCap":67749456},{"date":"2025-05-09","current":-0.873168,"twenty":-3.597611,"median":-1.128264,"eighty":-0.77066,"marketCap":67522954},{"date":"2025-05-16","current":-0.722039,"twenty":-3.5941,"median":-1.125796,"eighty":-0.77066,"marketCap":68761908},{"date":"2025-05-23","current":-0.780582,"twenty":-3.590118,"median":-1.116393,"eighty":-0.77066,"marketCap":74337198},{"date":"2025-05-30","current":-0.813107,"twenty":-3.574188,"median":-1.116393,"eighty":-0.771062,"marketCap":77434581},{"date":"2025-06-06","current":-0.806602,"twenty":-3.568833,"median":-1.109475,"eighty":-0.771062,"marketCap":76815104},{"date":"2025-06-13","current":-0.793592,"twenty":-3.568833,"median":-1.104156,"eighty":-0.771062,"marketCap":75576151},{"date":"2025-06-20","current":-0.741553,"twenty":-3.556287,"median":-1.086059,"eighty":-0.771062,"marketCap":70620338},{"date":"2025-06-27","current":-0.767573,"twenty":-3.551123,"median":-1.083246,"eighty":-0.771062,"marketCap":73098244},{"date":"2025-07-03","current":-0.715534,"twenty":-3.547456,"median":-1.080597,"eighty":-0.770083,"marketCap":68142431},{"date":"2025-07-11","current":-0.774077,"twenty":-3.545259,"median":-1.075336,"eighty":-0.767433,"marketCap":73717721},{"date":"2025-07-18","current":-0.761068,"twenty":-3.543661,"median":-1.071554,"eighty":-0.766627,"marketCap":72478768},{"date":"2025-07-25","current":-0.87165,"twenty":-3.538153,"median":-1.069177,"eighty":-0.76494,"marketCap":83009871},{"date":"2025-08-01","current":-0.728544,"twenty":-3.534684,"median":-1.066768,"eighty":-0.76198,"marketCap":69381384},{"date":"2025-08-08","current":-0.696019,"twenty":-3.52757,"median":-1.066568,"eighty":-0.760512,"marketCap":66284001},{"date":"2025-08-15","current":-0.735048,"twenty":-3.52304,"median":-1.062501,"eighty":-0.754563,"marketCap":70000861},{"date":"2025-08-22","current":-0.850216,"twenty":-3.52304,"median":-1.0582,"eighty":-0.754563,"marketCap":81863938},{"date":"2025-08-29","current":-0.856657,"twenty":-3.52304,"median":-1.052151,"eighty":-0.756473,"marketCap":82484119},{"date":"2025-09-05","current":-1.037006,"twenty":-3.521304,"median":-1.047489,"eighty":-0.758203,"marketCap":99849197},{"date":"2025-09-12","current":-1.198032,"twenty":-3.517135,"median":-1.054672,"eighty":-0.759205,"marketCap":115353731},{"date":"2025-09-19","current":-1.49432,"twenty":-3.513161,"median":-1.0582,"eighty":-0.760235,"marketCap":143882073},{"date":"2025-09-26","current":-1.326853,"twenty":-3.508755,"median":-1.062519,"eighty":-0.761068,"marketCap":127757358},{"date":"2025-10-03","current":-1.449233,"twenty":-3.501389,"median":-1.066668,"eighty":-0.761068,"marketCap":139540803},{"date":"2025-10-10","current":-2.466916,"twenty":-3.494763,"median":-1.066768,"eighty":-0.761394,"marketCap":237529457},{"date":"2025-10-17","current":-2.157746,"twenty":-3.494674,"median":-1.070114,"eighty":-0.761947,"marketCap":207760752},{"date":"2025-10-24","current":-2.177069,"twenty":-3.490558,"median":-1.072056,"eighty":-0.76265,"marketCap":209621296},{"date":"2025-10-31","current":-2.202833,"twenty":-3.484584,"median":-1.076786,"eighty":-0.764479,"marketCap":212102021},{"date":"2025-11-07","current":-2.580735,"twenty":-3.48444,"median":-1.080663,"eighty":-0.766165,"marketCap":250553265},{"date":"2025-11-14","current":-2.873161,"twenty":-3.475674,"median":-1.083358,"eighty":-0.766624,"marketCap":278943683},{"date":"2025-11-21","current":-2.905227,"twenty":-3.458821,"median":-1.094759,"eighty":-0.766867,"marketCap":282056893},{"date":"2025-11-28","current":-3.328505,"twenty":-3.450918,"median":-1.109339,"eighty":-0.767292,"marketCap":323151275},{"date":"2025-12-01","current":-3.328505,"twenty":-3.449057,"median":-1.109339,"eighty":-0.767362,"marketCap":323151275}],"updateTime":1764713276774},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PYXS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2580812297","title":"Pyxis Oncology Q3 EPS USD -0.35","url":"https://stock-news.laohu8.com/highlight/detail?id=2580812297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580812297?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:00","pubTimestamp":1762171206,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nPLXD532F4:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PYXS","BK4139"],"gpt_icon":0},{"id":"2580594297","title":"Pyxis Oncology Inc - Expected Cash Runway Through Data Milestones and Into Second Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2580594297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580594297?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:00","pubTimestamp":1762171206,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nPLXD532F4:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PYXS","BK4139"],"gpt_icon":0},{"id":"2580297667","title":"Press Release: Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2580297667","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580297667?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:00","pubTimestamp":1762171200,"startTime":"0","endTime":"0","summary":"-  Preliminary data from ongoing Phase 1 clinical studies of micvotabart pelidotin  in patients with recurrent and metastatic head and neck squamous cell carcinoma  expected in the fourth quarter of 2025. -  Clinical update to focus on preliminary data from Phase 1 monotherapy dose expansion study of MICVO in 2L/3L R/M HNSCC patients, including from both post platinum & PD-1 and post EGFR & PD-1 arms, and preliminary data from Phase 1/2 combination dose escalation study of MICVO and KEYTRUDA  in 1L/2L+ R/M HNSCC patients. -  Presented translational data at ESMO 2025 and AACR-NCI-EORTC providing meaningful insights into MICVO's first-in-concept non-cellular targeting antibody drug conjugate  mechanism of action. -  Expected cash runway through data milestones and into the second half of 2026. BOSTON, Nov. 03, 2025  -- Pyxis Oncology, Inc. , a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today provided a business update, and reported fina","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00BFTCPJ56.SGD","LU1116320901.HKD","LU1069347547.HKD","R","SG9999014542.SGD","SG9999002232.USD","LU0210528500.USD","BK4231","IE00B1BXHZ80.USD","BK4534","BK4232","BK4007","LU1116320737.USD","LU2487616109.SGD","LU1061106388.HKD","LU0122379950.USD","MRK","IE00BJJMRZ35.SGD","L","LU1430594728.SGD","LU1066051225.USD","LU1989772923.USD","LU2023250504.SGD","LU1066051498.USD","LU1093756325.SGD","LU1093756168.USD","LU0965509101.SGD","LU0320765646.SGD","LU1035773651.USD","LU1989772840.SGD","LU1917777945.USD","LU2461242641.AUD","BK4588","LU0965509283.SGD","LU0238689110.USD","LU2361044949.HKD","LU0208291251.USD","IE00BLSP4452.SGD","LU1585245621.USD","LU1983299246.USD","LU0965508806.USD","LU0006306889.USD","LU1037948897.HKD","BK4533","ADC","LU0265550359.USD","IE00B4R5TH58.HKD","IE00BLSP4239.USD","PYXS"],"gpt_icon":0},{"id":"2580292701","title":"Pyxis Oncology resumed with a Buy at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2580292701","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580292701?lang=en_us&edition=fundamental","pubTime":"2025-11-03 19:51","pubTimestamp":1762170661,"startTime":"0","endTime":"0","summary":"Stifel analyst Stephen Willey resumed coverage of Pyxis Oncology (PYXS) with a Buy rating and $9 price target The firm believes micvotabart pelidot...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pyxis-oncology-resumed-with-a-buy-at-stifel-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pyxis-oncology-resumed-with-a-buy-at-stifel-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","BK4139","PYXS","BK4127"],"gpt_icon":0},{"id":"2578620994","title":"Pyxis Oncology’s PYX-201 Study: A Promising Step in Solid Tumor Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2578620994","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578620994?lang=en_us&edition=fundamental","pubTime":"2025-10-28 03:30","pubTimestamp":1761593437,"startTime":"0","endTime":"0","summary":"Pyxis Oncology, Inc. (($PYXS)) announced an update on their ongoing clinical study. Pyxis Oncology, Inc. is conducting a Phase 1 clinical study tit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyxis-oncologys-pyx-201-study-a-promising-step-in-solid-tumor-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyxis-oncologys-pyx-201-study-a-promising-step-in-solid-tumor-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYXS","BK4139"],"gpt_icon":0},{"id":"2575695280","title":"Pyxis Oncology Announces New Clinical Data for MICVO ADC Targeting Solid Tumors to Be Presented at ESMO 2025 and AACR-NCI-EORTC","url":"https://stock-news.laohu8.com/highlight/detail?id=2575695280","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575695280?lang=en_us&edition=fundamental","pubTime":"2025-10-14 04:05","pubTimestamp":1760385916,"startTime":"0","endTime":"0","summary":"Pyxis Oncology Announces New Clinical Data for MICVO ADC Targeting Solid Tumors to Be Presented at ESMO 2025 and AACR-NCI-EORTC. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pyxis Oncology Inc. published the original content used to generate this news brief via GlobeNewswire  on October 13, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nNDL1ZBBXh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2210149790.SGD","BK4585","LU2210150020.SGD","PYXS","NDAQ","IE00BGHQF748.EUR","LU0314104364.USD","LU2095319765.USD","BK4112","IE00B3QW5Z07.USD","BK4588","BK4139","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2574041159","title":"Pyxis Oncology appoints Alex Kane as Senior Vice President Investor Relations and Capital Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2574041159","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574041159?lang=en_us&edition=fundamental","pubTime":"2025-10-09 19:30","pubTimestamp":1760009418,"startTime":"0","endTime":"0","summary":"Pyxis Oncology Inc. has appointed Alex Kane as Senior Vice President, Investor Relations & Capital Markets. Kane brings two decades of experience in investor relations and equity capital markets, most recently serving as Vice President of Equity Capital Markets at Guggenheim Securities. He has also held senior roles at Praxis Precision Medicines, PTC Therapeutics, W2O Group, NASDAQ, and Thomson Reuters.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pyxis Oncology Inc. published the original content used to generate this news brief via GlobeNewswire  on October 09, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nNDL4qgVyS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","PRAX","BK4588","IE00BKPKM429.USD","LU0314104364.USD","IE00BGHQF748.EUR","LU2095319765.USD","BK4112","BK4585","PTCT","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","PYXS","LU0109394709.USD","LU2210150020.SGD","LU0320765992.SGD","LU0889565916.HKD","BK4139","NDAQ"],"gpt_icon":0},{"id":"2573064546","title":"Kaltura Leads The Charge With Two Other Noteworthy Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2573064546","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573064546?lang=en_us&edition=fundamental","pubTime":"2025-10-06 19:05","pubTimestamp":1759748710,"startTime":"0","endTime":"0","summary":"As the U.S. stock market experiences mixed results with major indexes posting weekly gains, investors continue to navigate a landscape marked by new record highs and ongoing economic uncertainties such as the government shutdown. In this context, penny stocks—often representing smaller or emerging companies—remain an intriguing investment area despite their somewhat outdated moniker. By focusing on those with solid financials and growth potential, investors can uncover opportunities that...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pyxs/pyxis-oncology/news/kaltura-leads-the-charge-with-two-other-noteworthy-penny-sto","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pyxs/pyxis-oncology/news/kaltura-leads-the-charge-with-two-other-noteworthy-penny-sto","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4096","BK4587","MAPS","BK4551","BK4173","PYXS","PSHG","BK4023","BK4585","BK4157","BK4603","UUU","WDH","SES","BK4139","DDL","BK4021","BK4539","BK4543","BK4588","BK4134","LCUT","BK4528","BK4209","KLTR","BK4113","CINT","BABB","BK4180","BK4509"],"gpt_icon":1},{"id":"2572377701","title":"BRIEF-Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2572377701","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572377701?lang=en_us&edition=fundamental","pubTime":"2025-10-01 06:02","pubTimestamp":1759269750,"startTime":"0","endTime":"0","summary":"BRIEF-Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing RuleSept 30 (Reuters) - Pyxis Oncology Inc PYXS.O:PYXIS ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)Source text: ID:nGNXMXBs4Further company coverage: PYXS.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nTUA4XCCVS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PYXS"],"gpt_icon":0},{"id":"2572037140","title":"Pyxis Oncology Grants Stock Options to New Employees Under 2022 Inducement Plan in Accordance with Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2572037140","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572037140?lang=en_us&edition=fundamental","pubTime":"2025-10-01 04:24","pubTimestamp":1759263893,"startTime":"0","endTime":"0","summary":"Pyxis Oncology Inc. has granted stock options to seven newly hired employees, totaling 382,518 shares of the company's common stock. Of these, 261,268 stock options will vest over four years, with 25% vesting after the first year and the remainder vesting monthly over the following three years. An additional 121,250 stock options will fully vest on December 31, 2025. All options have an exercise price of $2.22 per share, reflecting the closing price of Pyxis Oncology's stock on the grant date, September 30, 2025, and carry a ten-year term.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pyxis Oncology Inc. published the original content used to generate this news brief via GlobeNewswire  on September 30, 2025, and is solely responsible ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nNDL1nj3vq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4588","BK4112","IE00BKPKM429.USD","LU2210150020.SGD","LU0314104364.USD","IE00B64PRP62.GBP","LU2095319765.USD","IE00BGHQF748.EUR","LU2210149790.SGD","PYXS","NDAQ","BK4139","BK4585"],"gpt_icon":0},{"id":"2572753371","title":"Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2572753371","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572753371?lang=en_us&edition=fundamental","pubTime":"2025-10-01 04:24","pubTimestamp":1759263840,"startTime":"0","endTime":"0","summary":"BOSTON, Sept.  30, 2025  (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation antibody-drug conjugate (‘ADC’) therapeutics for difficult-to-trea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/30/3159076/0/en/Pyxis-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SQQQ","TSYW.SI","BK4139","QLD",".IXIC","USJW.SI","PYXS","USAW.SI","QID","PSQ","MNQmain","NQmain","NVIW.SI","TQQQ"],"gpt_icon":1},{"id":"2564308961","title":"Pyxis Oncology Initiated at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2564308961","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564308961?lang=en_us&edition=fundamental","pubTime":"2025-09-04 22:04","pubTimestamp":1756994640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PYXS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 04, 2025 10:04 ET (14:04 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PYXS"],"gpt_icon":0},{"id":"2564379232","title":"Guggenheim Initiates Pyxis Oncology at Buy With $5 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2564379232","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564379232?lang=en_us&edition=fundamental","pubTime":"2025-09-04 19:33","pubTimestamp":1756985599,"startTime":"0","endTime":"0","summary":"Pyxis Oncology (PYXS) has an average rating of buy and mean price target of $6, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks an","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PYXS"],"gpt_icon":0},{"id":"2561641684","title":"Pyxis Oncology Inc. to Participate in Cantor Global Healthcare Conference and H.C. Wainwright Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2561641684","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561641684?lang=en_us&edition=fundamental","pubTime":"2025-08-21 19:30","pubTimestamp":1755775818,"startTime":"0","endTime":"0","summary":"Pyxis Oncology Inc. to Participate in Cantor Global Healthcare Conference and H.C. Wainwright Annual Global Investment Conference. Pyxis Oncology Inc., a clinical-stage company focused on developing antibody-drug conjugate therapeutics for challenging cancer types, will present at the 2nd Annual ADC and Novel Conjugates Partnering and Investment Summit in Boston, MA, on Tuesday, September 9, 2025, at 3:20 p.m. ET. The presentation will not be webcast.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pyxis Oncology Inc. published the original content used to generate this news brief via GlobeNewswire  on August 21, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDL2kTj5y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4588","LU2095319765.USD","IE00BGHQF748.EUR","PYXS","LU0314104364.USD","LU2210150020.SGD","LU2210149790.SGD","BK4139","IE00B3QW5Z07.USD","BK4112","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4585"],"gpt_icon":0},{"id":"2560019342","title":"Pyxis Oncology Price Target Maintained With a $5.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2560019342","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560019342?lang=en_us&edition=fundamental","pubTime":"2025-08-19 19:12","pubTimestamp":1755601920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PYXS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 19, 2025 07:12 ET (11:12 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS"],"gpt_icon":0},{"id":"2559396142","title":"Pyxis Oncology Reports Q2 2025 Revenues of $2.8M, Net Loss Widens to $18.4M, EPS at ($0.30)","url":"https://stock-news.laohu8.com/highlight/detail?id=2559396142","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559396142?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:08","pubTimestamp":1755202112,"startTime":"0","endTime":"0","summary":"Pyxis Oncology Inc. reported financial results for the second quarter of 2025, with revenues reaching $2.8 million, a significant increase from $0 in the same quarter of 2024. This revenue was primarily generated from a $3 million milestone related to the regulatory approval of suvemcitug in China, partially offset by $0.2 million in taxes. The company's net loss for the quarter ended June 30, 2025, was $18.4 million, compared to a net loss of $17.3 million in the corresponding quarter of the previous year. Excluding non-cash stock-based compensation expenses, the net loss stood at $15.3 million for the quarter, compared to $14.4 million in the prior year. Research and development expenses increased to $17.1 million from $14.0 million year-over-year, driven by heightened manufacturing and clinical trial-related expenses. Conversely, general and administrative expenses decreased to $5.4 million from $6.1 million, owing to reductions in corporate insurance, facilities costs, and professi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDL5wl5R8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS","NDAQ"],"gpt_icon":0},{"id":"2559961425","title":"BRIEF-Pyxis Oncology Q2 Net Income USD -18.354 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2559961425","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559961425?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:05","pubTimestamp":1755201947,"startTime":"0","endTime":"0","summary":"BRIEF-Pyxis Oncology Q2 Net Income USD -18.354 Million\n\n\nAug 14 (Reuters) - Pyxis Oncology Q2 basic EPS USD -0.3.\n\nQ2 income from operations USD -19.75 million\nQ2 EPS USD -0.3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nPLX804599:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PYXS"],"gpt_icon":0},{"id":"2559961182","title":"Pyxis Oncology Q2 EPS USD -0.3","url":"https://stock-news.laohu8.com/highlight/detail?id=2559961182","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559961182?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:05","pubTimestamp":1755201902,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nPLX804599:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PYXS","BK4139"],"gpt_icon":0},{"id":"2559796481","title":"Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2559796481","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559796481?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:05","pubTimestamp":1755201900,"startTime":"0","endTime":"0","summary":"– Phase 1 monotherapy expansion study of micvotabart pelidotin (MICVO) for recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients progressing well with preliminary data in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/14/3133853/0/en/Pyxis-Oncology-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU1023059063.AUD","LU1291159041.SGD","IE00B2B36J28.USD","LU0122379950.USD","IE00BN8TJ469.HKD","LU0006306889.USD","LU2106854487.HKD","SG9999014559.SGD","SG9999015358.SGD","LU0265550946.USD","LU1037948897.HKD","LU2361044949.HKD","IE00BLSP4239.USD","LU1162221912.USD","LU1934455863.HKD","LU1989772923.USD","BK4550","SG9999014567.USD","LU2324357040.USD","LU1066051225.USD","LU1934455277.USD","LU2361044865.SGD","MRK","BK4231","LU0289739699.SGD","LU0234572021.USD","LU1941712348.USD","LU0265550359.USD","IE00BBT3K403.USD","LU1989771016.USD","LU0208291251.USD","IE00BJT1NW94.SGD","ADC","BK4534","IE000M9KFDE8.USD","LU2089984988.USD","LU0965509101.SGD","LU1066051811.HKD","LU1917777945.USD","LU0058720904.USD","LU1057294990.SGD","LU0211331839.USD","LU0266013472.USD","LU1035773651.USD","LU1585245621.USD","BK4585","PYXS","LU0098860793.USD","BK4139"],"gpt_icon":0},{"id":"2557526327","title":"Pyxis Oncology Inc  expected to post a loss of 35 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2557526327","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557526327?lang=en_us&edition=fundamental","pubTime":"2025-08-08 19:18","pubTimestamp":1754651887,"startTime":"0","endTime":"0","summary":"Pyxis Oncology Inc  expected to post a loss of35cents a share - Earnings Preview Pyxis Oncology Inc PYXS.OQ PYXS.O is expected to  show no change in quarterly revenue when it reports  results on Augus","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U01PS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":46,"code":"91000000","status":"200"}]}}